609 related articles for article (PubMed ID: 21085569)
1. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.
Cox HS; McDermid C; Azevedo V; Muller O; Coetzee D; Simpson J; Barnard M; Coetzee G; van Cutsem G; Goemaere E
PLoS One; 2010 Nov; 5(11):e13901. PubMed ID: 21085569
[TBL] [Abstract][Full Text] [Related]
2. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R
BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696
[TBL] [Abstract][Full Text] [Related]
3. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
[TBL] [Abstract][Full Text] [Related]
4. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS
Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
Welekidan LN; Skjerve E; Dejene TA; Gebremichael MW; Brynildsrud O; Agdestein A; Tessema GT; Tønjum T; Yimer SA
PLoS One; 2020; 15(8):e0236362. PubMed ID: 32797053
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia.
Adane K; Ameni G; Bekele S; Abebe M; Aseffa A
BMC Public Health; 2015 Jun; 15():572. PubMed ID: 26092570
[TBL] [Abstract][Full Text] [Related]
7. Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India.
Isaakidis P; Das M; Kumar AM; Peskett C; Khetarpal M; Bamne A; Adsul B; Manglani M; Sachdeva KS; Parmar M; Kanchar A; Rewari BB; Deshpande A; Rodrigues C; Shetty A; Rebello L; Saranchuk P
PLoS One; 2014; 9(10):e110461. PubMed ID: 25333696
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.
Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G
BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269
[TBL] [Abstract][Full Text] [Related]
9. The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.
Hanrahan CF; Dorman SE; Erasmus L; Koornhof H; Coetzee G; Golub JE
PLoS One; 2012; 7(11):e49898. PubMed ID: 23226229
[TBL] [Abstract][Full Text] [Related]
10. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
[TBL] [Abstract][Full Text] [Related]
11. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
[TBL] [Abstract][Full Text] [Related]
12. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
Kenyon TA; Mwasekaga MJ; Huebner R; Rumisha D; Binkin N; Maganu E
Int J Tuberc Lung Dis; 1999 Jan; 3(1):4-11. PubMed ID: 10094163
[TBL] [Abstract][Full Text] [Related]
13. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
14. Second nationwide anti-tuberculosis drug resistance survey in Namibia.
Ruswa N; Mavhunga F; Roscoe JC; Beukes A; Shipiki E; van Gorkom J; Sawadogo S; Agolory S; Menzies H; Tiruneh D; Makumbi B; Bayer B; Zezai A; Campbell P; Alexander H; Kalisvaart N; Forster N
Int J Tuberc Lung Dis; 2019 Jul; 23(7):858-864. PubMed ID: 31439119
[TBL] [Abstract][Full Text] [Related]
15. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
Cox H; Hughes J; Daniels J; Azevedo V; McDermid C; Poolman M; Boulle A; Goemaere E; van Cutsem G
Int J Tuberc Lung Dis; 2014 Apr; 18(4):441-8. PubMed ID: 24670700
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
[TBL] [Abstract][Full Text] [Related]
17. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community.
Andrews JR; Shah NS; Weissman D; Moll AP; Friedland G; Gandhi NR
PLoS One; 2010 Dec; 5(12):e15735. PubMed ID: 21209951
[TBL] [Abstract][Full Text] [Related]
18. Emergence of multidrug-resistant tuberculosis in a community-based directly observed treatment programme in rural South Africa.
Davies GR; Pillay M; Sturm AW; Wilkinson D
Int J Tuberc Lung Dis; 1999 Sep; 3(9):799-804. PubMed ID: 10488888
[TBL] [Abstract][Full Text] [Related]
19. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
[TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant tuberculosis in Imo State, Southeast, Nigeria.
E Ahiarakwem II; Ekejindu IM; Akujobi CN; Aghanya IN
Niger J Clin Pract; 2020 Aug; 23(8):1172-1177. PubMed ID: 32788498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
